166 related articles for article (PubMed ID: 28371875)
1. Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.
Fox MD; Xiao L; Zhang M; Kamat AM; Siefker-Radtke A; Zhang L; Dinney CP; Czerniak B; Guo CC
Am J Clin Pathol; 2017 May; 147(5):500-506. PubMed ID: 28371875
[TBL] [Abstract][Full Text] [Related]
2. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
[TBL] [Abstract][Full Text] [Related]
3. Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder.
Nomura S; Suzuki Y; Akatsuka J; Endo Y; Shimizu A; Hamasaki T; Kimura G; Kondo Y
BMC Urol; 2020 Jun; 20(1):72. PubMed ID: 32571273
[TBL] [Abstract][Full Text] [Related]
4. Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin.
Sangoi AR; Chan E; Stohr BA; Kunju LP
Hum Pathol; 2020 Aug; 102():54-59. PubMed ID: 32673685
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.
Wang Z; Lu T; Du L; Hu Z; Zhuang Q; Li Y; Wang CY; Zhu H; Ye Z
Int J Clin Exp Pathol; 2012; 5(6):601-8. PubMed ID: 22949945
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study.
Sato K; Ueda Y; Kawamura K; Aihara K; Katsuda S
Pathol Res Pract; 2009; 205(3):189-94. PubMed ID: 19041193
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases.
Zheng L; Chen H; Zhao J; Roy-Chowdhuri S; Kamat AM; Alhalabi O; Gao J; Siefker-Radtke A; Hansel DE; Czerniak B; Guo CC
Hum Pathol; 2024 Jun; 148():1-6. PubMed ID: 38679207
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid urothelial carcinoma of the bladder.
Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L
Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma.
Croft PR; Lathrop SL; Feddersen RM; Joste NE
Arch Pathol Lab Med; 2005 Feb; 129(2):194-9. PubMed ID: 15679420
[TBL] [Abstract][Full Text] [Related]
11. [Plasmacytoid urothelial carcinoma of the urinary bladder. A study of 7 cases].
Gaafar A; Garmendia M; de Miguel E; Velasco V; Ugalde A; Bilbao FJ; de Petris G; López JI
Actas Urol Esp; 2008 Sep; 32(8):806-10. PubMed ID: 19013979
[TBL] [Abstract][Full Text] [Related]
12. Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases.
Wang G; Xiao L; Zhang M; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC
Hum Pathol; 2018 Sep; 79():57-65. PubMed ID: 29763719
[TBL] [Abstract][Full Text] [Related]
13. The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.
Keck B; Stoehr R; Wach S; Rogler A; Hofstaedter F; Lehmann J; Montironi R; Sibonye M; Fritsche HM; Lopez-Beltran A; Epstein JI; Wullich B; Hartmann A
Int J Cancer; 2011 Jul; 129(2):346-54. PubMed ID: 20878954
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases.
Mai KT; Park PC; Yazdi HM; Saltel E; Erdogan S; Stinson WA; Cagiannos I; Morash C
Eur Urol; 2006 Nov; 50(5):1111-4. PubMed ID: 16626859
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid urothelial carcinoma of the bladder.
Qin M; Wang G; Sun Y; He Q
Indian J Pathol Microbiol; 2014; 57(2):320-2. PubMed ID: 24943778
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections.
Sood S; Paner GP
Arch Pathol Lab Med; 2019 Dec; 143(12):1562-1567. PubMed ID: 30865491
[TBL] [Abstract][Full Text] [Related]
17. Pleural fluid metastasis of plasmacytoid urothelial carcinoma in comparison to micropapillary and conventional high-grade urothelial carcinoma: Cytologic and immuonohistochemical findings.
Wang BG; Woodward K; Menezes G; Wang ZQ; He R; Li W
Diagn Cytopathol; 2022 Sep; 50(9):E248-E254. PubMed ID: 35560555
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional Experience Focusing on Tumors With Borderline Features.
Oliver-Krasinski JM; Bidot S; Ingram JW; O'Toole KM; McKiernan JM; Tinsley M; Harik LR
Arch Pathol Lab Med; 2024 Feb; 148(2):223-229. PubMed ID: 37134243
[TBL] [Abstract][Full Text] [Related]
19. Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder.
Keck B; Wach S; Kunath F; Bertz S; Taubert H; Lehmann J; Stöckle M; Wullich B; Hartmann A
Ann Surg Oncol; 2013 Jul; 20(7):2440-5. PubMed ID: 23108554
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
